105 related articles for article (PubMed ID: 17693664)
1. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
[TBL] [Abstract][Full Text] [Related]
2. Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?
Yu J; Berga SL; Zou W; Rajakumar A; Man M; Sidell N; Taylor RN
J Clin Endocrinol Metab; 2020 Sep; 105(9):2983-95. PubMed ID: 32594141
[TBL] [Abstract][Full Text] [Related]
3. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
[TBL] [Abstract][Full Text] [Related]
4. Establishing the Role of PPARβ/δ in Carcinogenesis.
Peters JM; Gonzalez FJ; Müller R
Trends Endocrinol Metab; 2015 Nov; 26(11):595-607. PubMed ID: 26490384
[TBL] [Abstract][Full Text] [Related]
5. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR
Lu W; Huang J; Flores J; Li P; Wang W; Liu S; Zhang JH; Tang J
Exp Neurol; 2024 Feb; 372():114615. PubMed ID: 37995951
[TBL] [Abstract][Full Text] [Related]
6. PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury.
Qian B; Wang C; Li X; Ma P; Dong L; Shen B; Wu H; Li N; Kang K; Ma Y
Liver Int; 2023 Dec; 43(12):2808-2823. PubMed ID: 37833850
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.
Khozoie C; Borland MG; Zhu B; Baek S; John S; Hager GL; Shah YM; Gonzalez FJ; Peters JM
BMC Genomics; 2012 Nov; 13():665. PubMed ID: 23176727
[TBL] [Abstract][Full Text] [Related]
8. PPARβ/δ-ANGPTL4 axis mediates the promotion of mono-2-ethylhexyl phthalic acid on MYCN-amplified neuroblastoma development.
Liu Y; Hamid N; Manzoor R; Zhang BF; Liao YL; Wang JX; Pei DS
Sci Total Environ; 2024 Feb; 912():168949. PubMed ID: 38042186
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms.
Yao PL; Chen LP; Dobrzański TP; Phillips DA; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Oncotarget; 2015 Nov; 6(34):36319-37. PubMed ID: 26431381
[TBL] [Abstract][Full Text] [Related]
10. Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.
Elie-Caille C; Lascombe I; Péchery A; Bittard H; Fauconnet S
Mol Cell Biochem; 2020 Aug; 471(1-2):113-127. PubMed ID: 32519230
[TBL] [Abstract][Full Text] [Related]
11. PPARβ/δ as a promising molecular drug target for liver diseases: A focused review.
Meng X; Wang L; Du YC; Cheng D; Zeng T
Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102343. PubMed ID: 38641250
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of GW501516 and the role of Peroxisome proliferator-activated receptor β/δ and B-cell lymphoma 6 in inflammatory signaling in human pancreatic cancer cells.
Smith RW; Coleman JD; Thompson JT; Vanden Heuvel JP
Biochem Biophys Rep; 2016 Dec; 8():395-402. PubMed ID: 28955982
[TBL] [Abstract][Full Text] [Related]
13. Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ.
Zhang M; Barroso E; Ruart M; Peña L; Peyman M; Aguilar-Recarte D; Montori-Grau M; Rada P; Cugat C; Montironi C; Zarei M; Jurado-Aguilar J; Camins A; Balsinde J; Valverde ÁM; Wahli W; Palomer X; Vázquez-Carrera M
Biomed Pharmacother; 2023 Nov; 167():115623. PubMed ID: 37783154
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Wilms' tumour gene and its association with PPARβ/δ in healthy skin and melanoma of horses.
Rangel-Sánchez IY; Salas-Treviño D; Soto-Domínguez A; Garza-Rodríguez OI; Saucedo-Cárdenas O; Zapata-Benavides P; Zarate-Ramos JJ; Cedillo-Rosales S; Zamora-Ávila DE
Acta Vet Hung; 2021 Jan; 68(4):374-379. PubMed ID: 33459615
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Cell Proliferation and Differentiation by PPARbeta/delta.
Müller R; Rieck M; Müller-Brüsselbach S
PPAR Res; 2008; 2008():614852. PubMed ID: 18815620
[TBL] [Abstract][Full Text] [Related]
16. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
Han S; Ritzenthaler JD; Zheng Y; Roman J
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1238-49. PubMed ID: 18390835
[TBL] [Abstract][Full Text] [Related]
17. A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice.
Chen W; Gao R; Xie X; Zheng Z; Li H; Li S; Dong F; Wang L
Sci Rep; 2015 May; 5():9884. PubMed ID: 25943561
[TBL] [Abstract][Full Text] [Related]
18. New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
Sahebkar A; Chew GT; Watts GF
Expert Opin Pharmacother; 2014 Mar; 15(4):493-503. PubMed ID: 24428677
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
Péchery A; Fauconnet S; Bittard H; Lascombe I
Tumour Biol; 2016 Nov; 37(11):14789-14802. PubMed ID: 27638828
[TBL] [Abstract][Full Text] [Related]
20. Ligand-activated peroxisome proliferator-activated receptor β/δ modulates human endometrial cancer cell survival.
Ma JJ; Monsivais D; Dyson MT; Coon JS; Malpani S; Ono M; Zhao H; Xin H; Pavone ME; Kim JJ; Chakravarti D; Bulun SE
Horm Cancer; 2013 Dec; 4(6):358-70. PubMed ID: 23943160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
